Stock Research for HTBX


Featured Broker: Ally Invest

Get the due diligence for another stock.


HTBX Stock Chart & Research Data

The HTBX chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the HTBX chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


HTBX Due diligence Resources & Stock Charts

The HTBX stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View HTBX Detailed Price Forecast - CNN Money CNN View HTBX Detailed Summary - Google Finance
Yahoo View HTBX Detailed Summary - Yahoo! Finance Zacks View HTBX Stock Research & Analysis -

Stock Analysis

TradeIdeas View HTBX Trends & Analysis - Trade-Ideas Barrons View HTBX Major Holders - Barrons
NASDAQ View HTBX Call Transcripts - NASDAQ Seeking View HTBX Breaking News & Analysis - Seeking Alpha
Spotlight View HTBX Annual Report - OTC Report View HTBX OTC Short Report -
TradeKing View HTBX Fundamentals - TradeKing Charts View HTBX SEC Filings - Bar Chart
WSJ View Historical Prices for HTBX - The WSJ Morningstar View Performance/Total Return for HTBX - Morningstar
MarketWatch View the Analyst Estimates for HTBX - MarketWatch CNBC View the Earnings History for HTBX - CNBC
StockMarketWatch View the HTBX Earnings - StockMarketWatch MacroAxis View HTBX Buy or Sell Recommendations - MacroAxis
Bullish View the HTBX Bullish Patterns - American Bulls Short Pains View HTBX Short Pain Metrics -

Social Media Mentions

StockTwits View HTBX Stock Mentions - StockTwits PennyStocks View HTBX Stock Mentions - PennyStockTweets
Twitter View HTBX Stock Mentions - Twitter Invest Hub View HTBX Investment Forum News - Investor Hub
Yahoo View HTBX Stock Mentions - Yahoo! Message Board Seeking Alpha View HTBX Stock Mentions - Seeking Alpha

Financial & Transaction Holdings

SECform4 View Insider Transactions for HTBX - Insider Cow View Insider Transactions for HTBX - Insider Cow
CNBC View HTBX Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for HTBX - OTC Markets
Yahoo View Insider Transactions for HTBX - Yahoo! Finance NASDAQ View Institutional Holdings for HTBX - NASDAQ

Stock Charts

FinViz View HTBX Stock Insight & Charts - StockCharts View HTBX Investment Charts -
BarChart View HTBX Stock Overview & Charts - BarChart Trading View View HTBX User Generated Charts - Trading View

Latest Financial News for HTBX

Heat Biologics Stock Is a Worthwhile, Speculative Bet
Posted on Wednesday August 15, 2018

Investors still waiting for Heat Biologics (NASDAQ:HTBX) to trade at a market cap of $100 million will have to wait longer. The biotechnology company, whose market capitalization is just $43 million, which puts it in the nano-cap territory, does not have much to offer except for hope. On May 3, HTBX stock slumped by around 50% when the company filed a preliminary prospectus for the public sale of nearly 4.3 million shares.

Heat Biologics Reports Second Quarter 2018 Results and Provides Corporate Update
Posted on Tuesday August 14, 2018

Completed a capital raise of $20.7 million in the second quarter of 2018 On track to report key clinical milestones beginning in Q4 2018 DURHAM, NC / ACCESSWIRE / August 14, 2018 / Heat Biologics, Inc. ...

Stock Performance Review on Amicus Therapeutics and Three Other Biotech Stocks
Posted on Monday July 30, 2018

Stock Research Monitor: HEB, HTBX, and PBYI LONDON, UK / ACCESSWIRE / July 30, 2018/ If you want a free Stock Review on FOLD sign up now at . On Friday, benchmark US ...

HTBX: Heat Biologics: Making an ImPACT on Cancer
Posted on Monday July 16, 2018

The clinical-stage company is focused on activating T-cells with its off-the shelf ImPACT technology which activates CD8+ T-cells to induce immune responses. Its proprietary approach transforms live, allogenic cancer cells into osmotic pumps that secrete gp96 and tumor-associated peptides. The gp96 ferries the peptides to antigen presenting cells which activate the immune system.

Stock Market & Investing Books

Enter a stock symbol to view the stock details.